Skip to main content

Advertisement

Figure 6 | Molecular Cancer

Figure 6

From: In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

Figure 6

Tumour weights in nude mice following endometrial cancer cell xenografting and treatment with "high dose" (0.25%) or "low dose" (0.1%) fenofibrate. Top – n = 6 mice per group treated for 21 days. Middle – n = 8 mice per group treated for 14 days and Bottom – n = 8 mice per group treated for a further 10 days with fenofibrate alone. Tumour weights were lower in the high-dose fenofibrate-treated mice in the first experiment, but this was not repeated in the second experiment.

Back to article page